• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在高温下的微酸性缓冲液中,重组单克隆抗体中琥珀酰亚胺的积累。

Accumulation of succinimide in a recombinant monoclonal antibody in mildly acidic buffers under elevated temperatures.

作者信息

Chu Grace C, Chelius Dirk, Xiao Gang, Khor Hui K, Coulibaly Sururat, Bondarenko Pavel V

机构信息

Department of Pharmaceutics, Amgen, Inc., One Amgen Center Drive, MS 8-1-C, Thousand Oaks, California 91320, USA.

出版信息

Pharm Res. 2007 Jun;24(6):1145-56. doi: 10.1007/s11095-007-9241-4. Epub 2007 Mar 24.

DOI:10.1007/s11095-007-9241-4
PMID:17385019
Abstract

PURPOSE

The purpose of this paper was to identify the location of a succinimide and determine the rate of its formation and hydrolysis in a recombinant human monoclonal IgG2 antibody aged in mildly acidic buffers at elevated temperatures.

MATERIALS AND METHODS

Cation exchange (CEX) HPLC separated multiple Main Peaks and high levels (up to 50%) of basic variants, the identification of which was an analytical challenge and required several complementary techniques. The relative abundance of the CEX basic variants was used to quantify the percentage of succinimide and to study the rates of its formation and hydrolysis.

RESULTS

Mass decrease by approximately 18 Da for intact antibodies from the CEX basic fractions suggested succinimide formation from aspartic acid as the major modification. Reversed-phase HPLC/MS of the reduced and trypsin-digested samples detected an isoaspartate 30 (isoD30) in the light chain peptide A25-R37. Direct evidence that isoD30 was from succinimide was obtained by performing succinimide hydrolysis in H2(18)O followed by tryptic digestion in H2(16)O.

CONCLUSIONS

Succinimide formation increased as pH became more acidic, whereas its hydrolysis was faster as pH became neutral and alkaline. Succinimide hydrolysis in a denatured sample was estimated to have completed in less than 2 h, but approximately three days for a similar pH but without denaturant. These observations suggest that protein conformation affects succinimide hydrolysis.

摘要

目的

本文旨在确定琥珀酰亚胺的位置,并测定其在重组人单克隆IgG2抗体于温和酸性缓冲液中在高温下老化时的形成和水解速率。

材料与方法

阳离子交换(CEX)高效液相色谱法分离出多个主峰和高水平(高达50%)的碱性变体,对其进行鉴定是一项分析挑战,需要多种互补技术。CEX碱性变体的相对丰度用于定量琥珀酰亚胺的百分比,并研究其形成和水解速率。

结果

来自CEX碱性馏分的完整抗体质量减少约18 Da,表明天冬氨酸形成琥珀酰亚胺是主要修饰。还原和胰蛋白酶消化样品的反相高效液相色谱/质谱法在轻链肽A25-R37中检测到异天冬氨酸30(isoD30)。通过在H2(18)O中进行琥珀酰亚胺水解,然后在H2(16)O中进行胰蛋白酶消化,获得了isoD30来自琥珀酰亚胺的直接证据。

结论

随着pH值变得更酸性,琥珀酰亚胺的形成增加,而随着pH值变为中性和碱性,其水解更快。变性样品中的琥珀酰亚胺水解估计在不到2小时内完成,但在类似pH值但无变性剂的情况下约需三天。这些观察结果表明蛋白质构象影响琥珀酰亚胺水解。

相似文献

1
Accumulation of succinimide in a recombinant monoclonal antibody in mildly acidic buffers under elevated temperatures.在高温下的微酸性缓冲液中,重组单克隆抗体中琥珀酰亚胺的积累。
Pharm Res. 2007 Jun;24(6):1145-56. doi: 10.1007/s11095-007-9241-4. Epub 2007 Mar 24.
2
Succinimide formation at Asn 55 in the complementarity determining region of a recombinant monoclonal antibody IgG1 heavy chain.在重组单克隆抗体 IgG1 重链的互补决定区中天门冬酰胺 55 处形成琥珀酰亚胺。
J Pharm Sci. 2009 Oct;98(10):3509-21. doi: 10.1002/jps.21655.
3
18O labeling method for identification and quantification of succinimide in proteins.用于鉴定和定量蛋白质中琥珀酰亚胺的18O标记方法。
Anal Chem. 2007 Apr 1;79(7):2714-21. doi: 10.1021/ac0617870. Epub 2007 Feb 22.
4
Discovery and Control of Succinimide Formation and Accumulation at Aspartic Acid Residues in The Complementarity-Determining Region of a Therapeutic Monoclonal Antibody.发现并控制治疗性单克隆抗体互补决定区中天冬氨酸残基上琥珀酰亚胺的形成和积累。
Pharm Res. 2023 Jun;40(6):1411-1423. doi: 10.1007/s11095-022-03462-0. Epub 2023 Jan 10.
5
Accurate determination of succinimide degradation products using high fidelity trypsin digestion peptide map analysis.采用高保真胰蛋白酶消化肽图分析准确测定琥珀酰亚胺降解产物。
Anal Chem. 2011 Aug 1;83(15):5912-9. doi: 10.1021/ac200750u. Epub 2011 Jul 1.
6
Identification of Asp95 as the site of succinimide formation in recombinant human glial cell line-derived neurotrophic factor.确定Asp95为重组人胶质细胞源性神经营养因子中琥珀酰亚胺形成的位点。
Arch Biochem Biophys. 1998 Oct 15;358(2):377-84. doi: 10.1006/abbi.1998.0884.
7
Direct identification and quantification of aspartyl succinimide in an IgG2 mAb by RapiGest assisted digestion.通过RapiGest辅助消化直接鉴定和定量IgG2单克隆抗体中的天冬氨酰琥珀酰亚胺。
Anal Chem. 2009 Feb 15;81(4):1686-92. doi: 10.1021/ac802708s.
8
Understanding the pathway and kinetics of aspartic acid isomerization in peptide mapping methods for monoclonal antibodies.理解在单克隆抗体肽图分析方法中天门冬氨酸的异构化途径和动力学。
Anal Bioanal Chem. 2021 Mar;413(8):2113-2123. doi: 10.1007/s00216-021-03176-z. Epub 2021 Feb 5.
9
Characterization of succinimide stability during trypsin digestion for LC-MS analysis.用于液相色谱-质谱分析的胰蛋白酶消化过程中琥珀酰亚胺稳定性的表征。
Anal Biochem. 2017 Jun 1;526:1-8. doi: 10.1016/j.ab.2017.03.005. Epub 2017 Mar 6.
10
An Automated and Qualified Platform Method for Site-Specific Succinimide and Deamidation Quantitation Using Low-pH Peptide Mapping.一种基于低 pH 肽图的自动化和定量平台方法,用于对特定位置的琥珀酰亚胺和脱酰胺进行定量分析。
J Pharm Sci. 2019 Nov;108(11):3540-3549. doi: 10.1016/j.xphs.2019.07.019. Epub 2019 Jul 30.

引用本文的文献

1
Role of Charge Heterogeneity on Physical Stability of Monoclonal Antibody Biotherapeutic Products.电荷不均一性对单克隆抗体生物治疗产品物理稳定性的影响。
Pharm Res. 2024 Jul;41(7):1443-1454. doi: 10.1007/s11095-024-03730-1. Epub 2024 Jun 28.
2
Stability of Protein Pharmaceuticals: Recent Advances.蛋白质类药物的稳定性:最新进展
Pharm Res. 2024 Jul;41(7):1301-1367. doi: 10.1007/s11095-024-03726-x. Epub 2024 Jun 27.
3
Combination of On-Line and Off-Line Two-Dimensional Liquid Chromatography-Mass Spectrometry for Comprehensive Characterization of mAb Charge Variants and Precise Instructions for Rapid Process Development.

本文引用的文献

1
Intracellular protein modification associated with altered T cell functions in autoimmunity.与自身免疫中T细胞功能改变相关的细胞内蛋白质修饰。
J Immunol. 2006 Oct 1;177(7):4541-9. doi: 10.4049/jimmunol.177.7.4541.
2
Isoaspartyl post-translational modification triggers anti-tumor T and B lymphocyte immunity.异天冬氨酰翻译后修饰引发抗肿瘤T淋巴细胞和B淋巴细胞免疫。
J Biol Chem. 2006 Oct 27;281(43):32676-83. doi: 10.1074/jbc.M604847200. Epub 2006 Sep 1.
3
Improving mass accuracy of high performance liquid chromatography/electrospray ionization time-of-flight mass spectrometry of intact antibodies.
在线和离线二维液相色谱-质谱联用技术全面表征单抗电荷变异体及快速工艺开发的精准操作指南
Int J Mol Sci. 2023 Oct 14;24(20):15184. doi: 10.3390/ijms242015184.
4
Characterization of N-Terminal Asparagine Deamidation and Clipping of a Monoclonal Antibody.单克隆抗体N端天冬酰胺脱酰胺化及截短的表征
Antibodies (Basel). 2023 Sep 19;12(3):59. doi: 10.3390/antib12030059.
5
Identification and characterization of an unexpected isomerization motif in CDRH2 that affects antibody activity.鉴定和表征 CDRH2 中一个意想不到的异构化模体,该模体影响抗体活性。
MAbs. 2023 Jan-Dec;15(1):2215364. doi: 10.1080/19420862.2023.2215364.
6
Designing Formulation Strategies for Enhanced Stability of Therapeutic Peptides in Aqueous Solutions: A Review.设计提高治疗性肽在水溶液中稳定性的制剂策略:综述
Pharmaceutics. 2023 Mar 14;15(3):935. doi: 10.3390/pharmaceutics15030935.
7
Blueprint for antibody biologics developability.抗体生物制剂开发蓝图。
MAbs. 2023 Jan-Dec;15(1):2185924. doi: 10.1080/19420862.2023.2185924.
8
Discovery and Control of Succinimide Formation and Accumulation at Aspartic Acid Residues in The Complementarity-Determining Region of a Therapeutic Monoclonal Antibody.发现并控制治疗性单克隆抗体互补决定区中天冬氨酸残基上琥珀酰亚胺的形成和积累。
Pharm Res. 2023 Jun;40(6):1411-1423. doi: 10.1007/s11095-022-03462-0. Epub 2023 Jan 10.
9
Restoring the biological activity of crizanlizumab at physiological conditions through a pH-dependent aspartic acid isomerization reaction.通过依赖于 pH 值的天冬氨酸异构化反应,在生理条件下恢复 crizanlizumab 的生物学活性。
MAbs. 2023 Jan-Dec;15(1):2151075. doi: 10.1080/19420862.2022.2151075.
10
Risk-Based Control Strategies of Recombinant Monoclonal Antibody Charge Variants.重组单克隆抗体电荷变体的基于风险的控制策略
Antibodies (Basel). 2022 Nov 20;11(4):73. doi: 10.3390/antib11040073.
提高完整抗体的高效液相色谱/电喷雾电离飞行时间质谱的质量精度。
J Am Soc Mass Spectrom. 2006 Jun;17(6):867-872. doi: 10.1016/j.jasms.2006.02.023. Epub 2006 Apr 21.
4
Formation of pyroglutamic acid from N-terminal glutamic acid in immunoglobulin gamma antibodies.免疫球蛋白γ抗体中N端谷氨酸形成焦谷氨酸的过程。
Anal Chem. 2006 Apr 1;78(7):2370-6. doi: 10.1021/ac051827k.
5
Optimization of a reversed-phase high-performance liquid chromatography/mass spectrometry method for characterizing recombinant antibody heterogeneity and stability.用于表征重组抗体异质性和稳定性的反相高效液相色谱/质谱法的优化
J Chromatogr A. 2006 Jul 7;1120(1-2):112-20. doi: 10.1016/j.chroma.2006.01.016. Epub 2006 Jan 30.
6
Reversed-phase liquid chromatography/mass spectrometry analysis of reduced monoclonal antibodies in pharmaceutics.药物制剂中还原单克隆抗体的反相液相色谱/质谱分析
J Chromatogr A. 2006 Jan 13;1102(1-2):164-75. doi: 10.1016/j.chroma.2005.10.053. Epub 2005 Nov 17.
7
Identification and characterization of deamidation sites in the conserved regions of human immunoglobulin gamma antibodies.人免疫球蛋白γ抗体保守区域中天冬酰胺脱酰胺位点的鉴定与表征
Anal Chem. 2005 Sep 15;77(18):6004-11. doi: 10.1021/ac050672d.
8
De novo peptide sequencing based on a divide-and-conquer algorithm and peptide tandem spectrum simulation.基于分治算法和肽串联质谱模拟的从头肽测序
Anal Chem. 2004 Nov 1;76(21):6374-83. doi: 10.1021/ac0491206.
9
Prediction of low-energy collision-induced dissociation spectra of peptides.肽的低能量碰撞诱导解离光谱的预测。
Anal Chem. 2004 Jul 15;76(14):3908-22. doi: 10.1021/ac049951b.
10
A failure to repair self-proteins leads to T cell hyperproliferation and autoantibody production.无法修复自身蛋白质会导致T细胞过度增殖和自身抗体产生。
J Immunol. 2003 Sep 15;171(6):2840-7. doi: 10.4049/jimmunol.171.6.2840.